[How can diabetic retinopathy be therapeutically modified? Advanced glycosylation end products (AGEs) and hyperglycemic memory].
Hammes
H P
HP
III. Medizinische Klinik und Poliklinik, Universität Giessen.
D000818:Animals; D003930:Diabetic Retinopathy / Q000503:physiopathology / Q000628:therapy*; D017127:Glycation End Products, Advanced / Q000037:antagonists & inhibitors / Q000502:physiology*; D006801:Humans; D006943:Hyperglycemia / Q000503:physiopathology*; D011379:Prognosis
D017127:Glycation End Products, Advanced